rs373373098
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_003482.4(KMT2D):c.3819C>T(p.Cys1273=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000417 in 1,613,414 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00032 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00043 ( 6 hom. )
Consequence
KMT2D
NM_003482.4 synonymous
NM_003482.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.72
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 12-49049769-G-A is Benign according to our data. Variant chr12-49049769-G-A is described in ClinVar as [Benign]. Clinvar id is 259057.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-49049769-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.72 with no splicing effect.
BS2
High AC in GnomAd4 at 48 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KMT2D | NM_003482.4 | c.3819C>T | p.Cys1273= | synonymous_variant | 12/55 | ENST00000301067.12 | NP_003473.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KMT2D | ENST00000301067.12 | c.3819C>T | p.Cys1273= | synonymous_variant | 12/55 | 5 | NM_003482.4 | ENSP00000301067 | A2 | |
KMT2D | ENST00000683543.2 | c.3819C>T | p.Cys1273= | synonymous_variant | 12/56 | ENSP00000506726 | P4 | |||
KMT2D | ENST00000685166.1 | c.3819C>T | p.Cys1273= | synonymous_variant | 11/54 | ENSP00000509386 | A2 | |||
KMT2D | ENST00000692637.1 | c.3819C>T | p.Cys1273= | synonymous_variant | 11/54 | ENSP00000509666 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152182Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
47
AN:
152182
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000904 AC: 225AN: 248902Hom.: 2 AF XY: 0.00116 AC XY: 156AN XY: 135014
GnomAD3 exomes
AF:
AC:
225
AN:
248902
Hom.:
AF XY:
AC XY:
156
AN XY:
135014
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000427 AC: 624AN: 1461114Hom.: 6 Cov.: 34 AF XY: 0.000604 AC XY: 439AN XY: 726736
GnomAD4 exome
AF:
AC:
624
AN:
1461114
Hom.:
Cov.:
34
AF XY:
AC XY:
439
AN XY:
726736
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000315 AC: 48AN: 152300Hom.: 1 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74474
GnomAD4 genome
AF:
AC:
48
AN:
152300
Hom.:
Cov.:
32
AF XY:
AC XY:
38
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
34
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Kabuki syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 25, 2023 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 26, 2019 | - - |
KMT2D-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 23, 2022 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at